Nerre Therapeutics

Closed

Stevenage, United Kingdom · Founded 2012 · $77.0M raised

Headquarters
Stevenage
Founded
2012
Total Funding
$77.0M
Last Round
$31.4M Series BNov 2012
Rounds
3

About

NeRRe Therapeutics is a Stevenage, UK-based clinical-stage biotechnology company focused on developing neurokinin receptor antagonists. Founded in 2012 as a spinout from GSK, which transferred its NK antagonist portfolio and associated intellectual property to NeRRe, the company has built a unique pipeline targeting conditions caused by neuronal hypersensitivity. Led by CEO Mary Kerr—whose team previously sold sister company KaNDy Therapeutics to Bayer for $425M upfront—NeRRe is backed by Advent Life Sciences, Columbus Venture Partners, Forbion Capital Partners, Fountain Healthcare Partners, and OrbiMed Advisors. The company's website now displays a notice that it has ceased trading.

Summary

Nerre Therapeutics is a Biotech company based in Stevenage, United Kingdom, founded in 2012. It has raised $77.0M in total across 3 rounds, most recently a $31.4M Series B round in Nov 2012.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries ANov 2012
$18.4M

Sign up to see all 3 rounds

Series B through Series A — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nerre Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nerre-therapeutics"><img src="https://indexed.vc/api/badge/company/nerre-therapeutics" alt="Nerre Therapeutics on Indexed.vc" width="260" height="76" /></a>